Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity-Reference-Cited by-同舟云学术

Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity

Published:2012-09 Issue:38 Volume:287 Page:31983-31993
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Winiarska Magdalena,Nowis Dominika,Bil Jacek,Glodkowska-Mrowka Eliza,Muchowicz Angelika,Wanczyk Malgorzata,Bojarczuk Kamil,Dwojak Michal,Firczuk Malgorzata,Wilczek Ewa,Wachowska Malgorzata,Roszczenko Katarzyna,Miaczynska Marta,Chlebowska Justyna,Basak Grzegorz Wladyslaw,Golab Jakub

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference41 articles.

1. Direct effect of rituximab in B-cell-derived lymphoid neoplasias: mechanism, regulation, and perspectives;Bezombes;Mol. Cancer Res.,2011

2. Molecular mechanisms of the antitumor effects of anti-CD20 antibodies;Winiarska;Front. Biosci.,2011

3. Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma—a randomized phase II trial of the Minnie Pearl Cancer Research Network;Hainsworth;J. Clin. Oncol.,2005

4. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J. Clin. Oncol.,1998

5. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59;Golay;Blood,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy of anti-CD20 antibodies in neurological and neuromuscular diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway;Chinese Medical Journal;2023-04-28

3. Distinct mechanisms underlying therapeutic potentials of CD20 in neurological and neuromuscular disease;Pharmacology & Therapeutics;2022-10

4. Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma;International Journal of Molecular Sciences;2022-01-28

5. The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy;Haematologica;2020-06